• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 369-383 of 521 results

2189 Exhibit: Exh 2189 FDA, Challenge and Opportunity White Paper 2004

Document IPR2016-00712, No. 2189-80 Exhibit - Exh 2189 FDA, Challenge and Opportunity White Paper 2004 (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2227 Exhibit: Exh 2227 Reactions 2009 to Kawaguchi

Document IPR2016-00712, No. 2227-117 Exhibit - Exh 2227 Reactions 2009 to Kawaguchi (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2046 Exhibit: Exh 2046 Zielinski

Document IPR2016-00712, No. 2046 Exhibit - Exh 2046 Zielinski (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

2261 Exhibit: Exhibit 2261 McSorley Deposition Transcript 41917 PUBLIC Version

Document IPR2016-00712, No. 2261-202 Exhibit - Exhibit 2261 McSorley Deposition Transcript 41917 PUBLIC Version (P.T.A.B. May. 10, 2017)

cite Cite Document
Analyze

2007 Exhibit: Exh 2007 Berry

Document IPR2016-00712, No. 2007 Exhibit - Exh 2007 Berry (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

1086 Exhibit: Exhibit 1086 United States Patent 4814470

Document IPR2016-00712, No. 1086-155 Exhibit - Exhibit 1086 United States Patent 4814470 (P.T.A.B. Mar. 14, 2017)

cite Cite Document
Analyze

2198 Exhibit: Exh 2198 Gleevec Label

Document IPR2016-00712, No. 2198-88 Exhibit - Exh 2198 Gleevec Label (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2122 Exhibit: Exh 2122 Small 2006 Abstract

Document IPR2016-00712, No. 2122-19 Exhibit - Exh 2122 Small 2006 Abstract (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2029 Exhibit: Exh 2029 OncoGenex Press Release

Document IPR2016-00712, No. 2029 Exhibit - Exh 2029 OncoGenex Press Release (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

2063 Exhibit: Exh 2063 Herceptin Label

Document IPR2016-00712, No. 2063 Exhibit - Exh 2063 Herceptin Label (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

2138 Exhibit: Exh 2138 About NCCN Guidelines

Document IPR2016-00712, No. 2138-32 Exhibit - Exh 2138 About NCCN Guidelines (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2149 Exhibit: Exh 2149 Public Tate Declaration

Document IPR2016-00712, No. 2149-62 Exhibit - Exh 2149 Public Tate Declaration (P.T.A.B. Dec. 23, 2016)

cite Cite Document
Analyze

2110 Exhibit: Exh 2110 Latif

Document IPR2016-00712, No. 2110 Exhibit - Exh 2110 Latif (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

2075 Exhibit: Exh 2075 Motzer

Document IPR2016-00712, No. 2075 Exhibit - Exh 2075 Motzer (P.T.A.B. Jun. 24, 2016)

cite Cite Document
Analyze

1062 Exhibit: Exhibit 1062 Mitoxantrone Chemotherapy Drugs Chemocare

Document IPR2016-00712, No. 1062-167 Exhibit - Exhibit 1062 Mitoxantrone Chemotherapy Drugs Chemocare (P.T.A.B. Mar. 14, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 25 26 27 28 29 ... >>